Log in to save to my catalogue

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3090014

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

About this item

Full title

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

Publisher

Chichester, UK: John Wiley & Sons, Ltd

Journal title

EMBO reports, 2011-05, Vol.12 (5), p.463-469

Language

English

Formats

Publication information

Publisher

Chichester, UK: John Wiley & Sons, Ltd

More information

Scope and Contents

Contents

Mutations in isocitrate dehydrogenases (IDHs) have a gain‐of‐function effect leading to
R
(−)‐2‐hydroxyglutarate (
R‐
2HG) accumulation. By using biochemical, structural and cellular assays, we show that either or both
R
‐ and
S
‐2HG inhibit 2‐oxoglutarate (2OG)‐dependent oxygenases with varying potencies. Half‐maximal inhib...

Alternative Titles

Full title

The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3090014

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3090014

Other Identifiers

ISSN

1469-221X

E-ISSN

1469-3178

DOI

10.1038/embor.2011.43

How to access this item